Skip to main content
25 February 2021
Last updated:
Wednesday 24 February 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Klaas Zuideveld becomes CEO of Versameb

Saturday 16 January 2021
Company
Versameb AG
Appointee Name
Klaas 
Zuideveld
Country

Switzerland

Klaas Zuideveld has been appointed chief executive of Versameb AG, a Swiss company developing RNA-based therapeutics. He was previously chief development officer. At the same time, Friedrich Metzger, the company’s co-founder and former CEO, has become chief scientific officer. Versameb is advancing two assets based on its RNA platform from discovery into clinical development.

Dr Zuideveld formerly led pharma partnerships at Caris Life Sciences Inc. Before that he worked at Roche where amongst other things, he led the clinical development of Avastin.

Versamed announced the appointment on 8 January 2021.

Copyright 2021 Evernow Publishing Ltd

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Microbiotica expands management team
Wednesday February 10 2021
Philippe Dro joins Scenic Biotech as independent chairman
Wednesday February 10 2021
NOXXON announces senior appointment to its new advisory board
Wednesday February 10 2021
Wendy Levin joins Biofidelity as chief medical officer
Wednesday February 10 2021
VarmX appoints Gerard Short as chief medical officer
Wednesday February 10 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.